Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

ClinicalTrials.gov ID: NCT02117934

Public ClinicalTrials.gov record NCT02117934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the safety and immunogenicity of an investigational hepatitis B vaccine (HEPLISAV) in adults 18 to 70 years of age.

Study identification

NCT ID
NCT02117934
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
8,374 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2014 (Type not available)
Primary completion
Oct 2015 (Actual)
Completion
Oct 2015 (Actual)
Last update posted
Mar 20, 2019

2014 – 2015

United States locations

U.S. sites
40
U.S. states
17
U.S. cities
34
Facility City State ZIP Site status
Clinical Research Advantage, Inc. Birmingham Alabama 35211 —
Clinical Research Advantage, Inc. Chandler Arizona 85224 —
Radiant Research Chandler Arizona 85224 —
Clinical Research Advantage, Inc. Glendale Arizona 85306 —
Clinical Research Advantage, Inc. Mesa Arizona 85206 —
Clinical Research Advantage, Inc. Mesa Arizona 85213 —
Clinical Research Advantage, Inc. Phoenix Arizona 85018 —
Clinical Research Advantage, Inc. Phoenix Arizona 85020 —
Clinical Research Advantage, Inc. Phoenix Arizona 85050 —
Radiant Research Scottsdale Arizona 85251 —
Clinical Research Advantage, Inc. Tempe Arizona 85283 —
Radiant Research Tucson Arizona 85712 —
Clinical Research Advantage, Inc. Tucson Arizona 85741 —
Radiant Research Santa Rosa California 95405 —
Clinical Research Advantage, Inc. Vista California 92083 —
Clinical Research Advantage, Inc. Centennial Colorado 80112 —
Clinical Research Advantage, Inc. Colorado Springs Colorado 80922 —
Radiant Research Denver Colorado 80239 —
Radiant Research Pinellas Park Florida 33781 —
Radiant Research Atlanta Georgia 30342 —
Radiant Research Chicago Illinois 60654 —
Clinical Research Advantage, Inc Evansville Indiana 47725 —
Clinical Research Advantage, Inc. Council Bluffs Iowa 51503 —
Radiant Research Edina Minnesota 55435 —
Radiant Research St Louis Missouri 83141 —
Clinical Research Advantage, Inc. Elkhorn Nebraska 68022 —
Clinical Research Advantage, Inc. Fremont Nebraska 68025 —
Clinical Research Advantage, Inc. Omaha Nebraska 68124 —
Clinical Research Advantage, Inc. Henderson Nevada 89052 —
Clinical Research Advantage, Inc. Las Vegas Nevada 89128 —
Radiant Research Akron Ohio 44311 —
Radiant Research Cincinnati Ohio 45249 —
Radiant Research Columbus Ohio 43212 —
Clinical Research Advantage, Inc. Anderson South Carolina 29621 —
Radiant Research Anderson South Carolina 29621 —
Radiant Research Greer South Carolina 29650 —
Radiant Research Dallas Texas 75231 —
Clinical Research Advantage, Inc. Plano Texas 75093 —
Radiant Research San Antonio Texas 78229 —
Radiant Research Murray Utah 84123 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02117934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 20, 2019 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02117934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →